Costs and cost-effectiveness of the meeting centres support programme for people living with dementia and carers in Italy, Poland and the UK: The MEETINGDEM study

被引:8
|
作者
Henderson, Catherine [1 ]
Rehill, Amritpal [1 ]
Brooker, Dawn [2 ]
Evans, Simon C. [2 ]
Evans, Shirley B. [2 ]
Bray, Jennifer [2 ]
Saibene, Francesca Lea [3 ]
Scorolli, Claudia [4 ]
Szczesniak, Dorota [5 ]
d'Arma, Alessia [3 ]
Lion, Katarzyna [6 ]
Atkinson, Teresa [2 ]
Farina, Elisabetta [3 ]
Rymaszewska, Joanna [5 ]
Chattat, Rabih [4 ]
Meiland, Franka [7 ]
Droes, Rose-Marie [7 ]
Knapp, Martin [1 ]
机构
[1] London Sch Econ & Polit Sci, Care Policy & Evaluat Ctr, London, England
[2] Univ Worcester, Assoc Dementia Studies, Worcester, England
[3] IRCCS Fdn Don Carlo Gnocchi ONLUS, Milan, Italy
[4] Univ Bologna, Bologna, Italy
[5] Wroclaw Med Univ, Wroclaw, Poland
[6] Griffith Univ, Nathan, Qld, Australia
[7] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Amsterdam, Netherlands
关键词
cost-effectiveness; dementia and cognitive disorders; post-diagnostic support; psychosocial interventions;
D O I
10.1111/hsc.13281
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We examined the costs and cost-effectiveness of the Meeting Centre Support Programme (MCSP) implemented and piloted in the UK, Poland and Italy, replicating the Dutch Meeting Centre model. Dutch Meeting Centres combine day services for people with dementia with carer support. Data were collected over 2015-2016 from MCSP and usual care (UC) participants (people with dementia-carer dyads) at baseline and 6 months. We examined participants' health and social care (HSC), and societal costs, including Meeting Centre (MC) attendances. Costs and outcomes in MCSP and UC groups were compared. Primary outcomes: Persons with dementia: quality-adjusted life years (EQ-5D-5L-derived); QOL-AD. DQoL was examined as a secondary outcome. Carers: Short Sense of Competence Questionnaire (SSCQ). Incremental cost-effectiveness ratios (ICER) and cost-effectiveness acceptability curves were obtained by bootstrapping outcome and cost regression estimates. Eighty-three MCSP and 69 UC dyads were analysed. The 6-month cost of providing MCSP was euro4,703; participants with dementia attended MC a mean of 45 times and carers 15 times. Including intervention costs, adjusted 6-month HSC costs were euro5,941higher in MCSP than in UC. From the HSC perspective: in terms of QALY, the probability of cost-effectiveness was zero over willingness-to-pay (WTP) ranging from euro0 to euro350,000. On QOL-AD, the probability of cost-effectiveness of MCSP was 50% at WTP of euro5,000 for a one-point increase. A one-point gain in the DQoL positive affect subscale had a probability of cost-effectiveness of 99% at WTP over euro8,000. On SSCQ, no significant difference was found between MCSP and UC. Evidence for cost-effectiveness of MCSP was mixed but suggests that it may be cost-effective in relation to gains in dementia-specific quality of life measures. MCs offer effective tailored post-diagnostic support services to both people with dementia and carers in a context where few evidence-based alternatives to formal home-based social services may be available.
引用
收藏
页码:1756 / 1768
页数:13
相关论文
共 50 条
  • [41] Cost-effectiveness of a preferred intensity exercise programme for young people with depression compared with treatment as usual: an economic evaluation alongside a clinical trial in the UK
    Turner, David
    Carter, Tim
    Sach, Tracey
    Guo, Boliang
    Callaghan, Patrick
    BMJ OPEN, 2017, 7 (11):
  • [42] Does the Meeting Centres Support Programme reduce unmet care needs of community-dwelling older people with dementia? A controlled, 6-month follow-up Polish study
    Mazurek, Justyna
    Szczesniak, Dorota
    Lion, Katarzyna Malgorzata
    Droes, Rose-Marie
    Karczewski, Maciej
    Rymaszewska, Joanna
    CLINICAL INTERVENTIONS IN AGING, 2019, 14 : 113 - 122
  • [43] Cost-effectiveness of screening and treating alcohol use and depression among people living with HIV in Zimbabwe: a mathematical modeling study
    Su, Jasmine I-Shin
    Yeo, Yao-rui
    Jeetoo, Mellesia
    Morojele, Neo K.
    Francis, Joel M.
    Shenoi, Sheela
    Braithwaite, R. Scott
    BMC MEDICINE, 2024, 22 (01):
  • [44] Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial
    Jennifer Wenborn
    Sinéad Hynes
    Esme Moniz-Cook
    Gail Mountain
    Fiona Poland
    Michael King
    Rumana Omar
    Steven Morris
    Myrra Vernooij-Dassen
    David Challis
    Susan Michie
    Ian Russell
    Catherine Sackley
    Maud Graff
    Aidan O’Keeffe
    Nadia Crellin
    Martin Orrell
    Trials, 17
  • [45] Community occupational therapy for people with dementia and family carers (COTiD-UK) versus treatment as usual (Valuing Active Life in Dementia [VALID] programme): study protocol for a randomised controlled trial
    Wenborn, Jennifer
    Hynes, Sinead
    Moniz-Cook, Esme
    Mountain, Gail
    Poland, Fiona
    King, Michael
    Omar, Rumana
    Morris, Steven
    Vernooij-Dassen, Myrra
    Challis, David
    Michie, Susan
    Russell, Ian
    Sackley, Catherine
    Graff, Maud
    O'Keeffe, Aidan
    Crellin, Nadia
    Orrell, Martin
    TRIALS, 2016, 17
  • [46] The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial
    Grant, A.
    Wileman, S.
    Ramsay, C.
    Boike, L.
    Epstein, D.
    Sculpher, M.
    Macran, S.
    Kilonzo, M.
    Vale, L.
    Francis, J.
    Mowat, A.
    Krukowski, Z.
    Heading, R.
    Thursz, M.
    Russell, I.
    Campbell, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2008, 12 (31) : 1 - +
  • [47] A mixed-methods feasibility study of a goal-focused manualised intervention to support people with dementia to stay living independently at home with support from family carers: NIDUS (New Interventions for Independence in Dementia Study) Family
    Rapaport, Penny
    Burton, Alexandra
    Palomo, Marina
    Griffiths, Jessica
    Kelleher, Daniel
    Leverton, Monica
    Vickerstaff, Victoria
    Barber, Julie
    Bird, Megan
    Budgett, Jessica
    Birch, Jodie
    Rockwood, Kenneth
    Downs, Murna
    Lord, Kathryn
    Kales, Helen C.
    Livingston, Gill
    Riley, Peter
    Cooper, Claudia
    AGING & MENTAL HEALTH, 2021, 25 (08) : 1463 - 1474
  • [48] Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial
    Annabel Sandra Mueller-Stierlin
    Friedrich Meixner
    Anne Kohlmann
    Mara Schumacher
    Anke Hänsel
    Melanie Pouwels
    Nicole Bias
    Sabrina Hartl
    Jessica Reichstein
    Elke Prestin
    Nils Greve
    Thomas Becker
    Reinhold Kilian
    Trials, 21
  • [49] Effectiveness and cost-effectiveness of a community-based mental health care programme (GBV) for people with severe mental illness in Germany: study protocol for a randomised controlled trial
    Mueller-Stierlin, Annabel Sandra
    Meixner, Friedrich
    Kohlmann, Anne
    Schumacher, Mara
    Haensel, Anke
    Pouwels, Melanie
    Bias, Nicole
    Hartl, Sabrina
    Reichstein, Jessica
    Prestin, Elke
    Greve, Nils
    Becker, Thomas
    Kilian, Reinhold
    TRIALS, 2020, 21 (01)
  • [50] WHEDA study: Effectiveness of occupational therapy at home for older people with dementia and their caregivers - The design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres
    Voigt-Radloff S.
    Graff M.
    Leonhart R.
    Schornstein K.
    Vernooij-Dassen M.
    Olde-Rikkert M.
    Huell M.
    BMC Geriatrics, 9 (1)